Allworth Financial’s BeOne Medicines Ltd ONC Stock Holding History

Allworth Financial’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.7K	Buy	76 +3	+4%	+$884	﹤0.01%	3128
2026 Q1	$21.7K	Buy	73 +20	+38%	+$6.47K	﹤0.01%	2936
2025 Q4	$16.1K	Buy	53 +7	+15%	+$2.29K	﹤0.01%	2950
2025 Q3	$15.7K	Buy	46 +33	+254%	+$10K	﹤0.01%	2848
2025 Q2	$3.15K	Buy	13 +8	+160%	+$1.96K	﹤0.01%	3507
2025 Q1	$1.28K	Buy	5 +4	+400%	+$935	﹤0.01%	3380
2024 Q4	$223	Buy	+1	New	+$204	﹤0.01%	3765
2024 Q3	–	Sell	-1	Closed	-$155	–	3854
2024 Q2	$155	Sell	1 -2	-67%	-$308	﹤0.01%	3577
2024 Q1	$470	Buy	+3	New	+$483	﹤0.01%	3299

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Allworth Financial's ONC Position: Q2 2026 in Review

Allworth Financial increased its BeOne Medicines Ltd (ONC) stake by 4.1% in Q2 2026, buying an estimated $884 and bringing the position to 76 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3128.

Allworth Financial first reported a position in ONC in Q1 2024 and has held it in 9 quarters since. The position peaked at $21.7K in Q1 2026. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Allworth Financial held 76 shares of BeOne Medicines Ltd worth $21.7K as of Q2 2026.
Allworth Financial bought 3 BeOne Medicines Ltd shares in Q2 2026, an estimated $884.
BeOne Medicines Ltd made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3128 holding.
Allworth Financial first reported a position in BeOne Medicines Ltd in Q1 2024 and has held it in 9 quarters since.
Allworth Financial's BeOne Medicines Ltd position peaked at $21.7K in Q1 2026.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.